MCADD 2023 _ Event Postponement
This is to inform that due to some circumstances beyond the organizer control, “International Conference on Medicinal Chemistry, Computer Aided Drug Design and Delivery” (MCADD 2023) Hybrid event during September 14-16, 2023 at Valencia, Spain has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at medicinal-chemistry@magnusconference.com or call + 1 (702) 988 2320.
International Conference on Medicinal Chemistry, Computer Aided Drug Design and Delivery
September 14-16, 2023
Applied Medicinal Chemistry
Medicinal chemistry is a field that combines chemistry, particularly synthetic organic chemistry, with pharmacology and other biological disciplines to work on the design, chemical synthesis, and commercialization of pharmacological agents or bioactive compounds (drugs). In its most typical form, applied medicinal chemistry focuses on tiny organic compounds. Applied medicinal chemistry includes synthetic organic chemistry, natural product chemistry, and computational chemistry, all of which are used in conjunction with chemical biology, enzymology, and structural biology to identify and develop new therapeutic medicines. Chemical substances that can be used as pharmaceutical medications are researched and developed by medicinal chemists. To develop and test novel drug products, they work in groups with other scientists and engineers. They also assist in the development of new and improved manufacturing procedures for the mass production of new pharmaceuticals.
- Enzymology
- Structure Biology
- Computational Chemistry
- Chemical Biology
Submit your abstract Today
Title : A qsar survey on tyrosine kinase inhibitors
Atefeh Hajiagha Bozorgi, Faculty of pharmacy, Iran (Islamic Republic of)
Title : Abbott diagnostics: COVID-19 inactivation, nucleocapsid antigen automated immunoassay development, and variant testing for automated and lateral flow assays binaxnow™ and panbio™
Philip M Hemken, Abbott Laboratories, United States
Title : Synthesis, antibacterial activity of 3-amino 5-methoxyl-2-methyl quinazolin-4(3H)-one an amino-6-methoxyl-2-methyl of 4H–benzo[d] [1,3]–oxazine–4–one
Osarumwense Peter Osarodion, Ondo State University of Sciences and Technology, Nigeria
Title : Tackling mycobacterium tuberculosis resistance with tailored isatin-pyrimidine hybrids enoyl acyl carrier protein reductase (Inha)
Amgad Albohy, The British University in Egypt (BUE), Egypt
Title : Transition metal complexes/Organometallic compounfs as anticancer drugs
Prakash kinthda, Nims university,jaipur,rajasthan, India
Title : New n-ribosides and n-mannosides of rhodanine derivatives with anticancer activity on leukaemia cell line: Design, synthesis, dft and molecular modelling studies
Ahmed, Kafrelsheikh University, Egypt